Elizabeth Crabtree‐Hartman

Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models

Egle Cekanaviciute, Bryan B. Yoo, Tessel F. Runia et al. · Proceedings of the National Academy of Sciences · 2017 · 1.1K citations · Full text

Life Sciences, Immunology, Microbiology +17

Long‐term evolution of multiple sclerosis disability in the treatment era

Bruce Cree, Pierre‐Antoine Gourraud, Carolyn Bevan et al. · Annals of Neurology · 2016 · 436 citations · Full text

Life Sciences, Neurology, Disability Management +16

Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment

Stacy E. Hatcher, Emmanuelle Waubant, Bardia Nourbakhsh et al. · JAMA Neurology · 2016 · 213 citations · Full text

Life Sciences, Immunology, Neurology +13

Reduction of CD8 ⁺ T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate

Collin M. Spencer, Elizabeth Crabtree‐Hartman, Klaus Lehmann‐Horn et al. · Neurology Neuroimmunology & Neuroinflammation · 2015 · 186 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Continuous daily assessment of multiple sclerosis disability using remote step count monitoring

Valerie J. Block, Antoine Lizée, Elizabeth Crabtree‐Hartman et al. · Journal of Neurology · 2016 · 146 citations · Full text

Medicine, Neurology, Rehabilitation Medicine +16